Literature DB >> 4065451

Alterations in alanine metabolism in diabetic dogs during short-term treatment with an artificial B cell.

E J Freyse, U Fischer, G Albrecht, E Salzsieder.   

Abstract

The flux rates of plasma glucose and alanine were studied isotopically (6-3H-glucose and U-14C-alanine simultaneously) in resting chronically diabetic dogs during short-term treatment with an artificial B cell where the insulin was infused into a peripheral vein. Despite perfect blood glucose control and normal glucose flux rates, the concentration and rates of appearance and disappearance of alanine were significantly elevated in the diabetic animals before, during and after an exogenous glucose load. The incorporation of the carbon moiety of alanine into circulating glucose was also increased, but diminished to a near-normal extent when exogenous glucose was given. The plasma clearance rates for alanine in the diabetic dogs were normal throughout the study. It is concluded that normal blood glucose control in diabetes does not necessarily mean normalization of the entire metabolic network. On the basis of peripheral hyperinsulinaemia alanine formation from glucose and branched chain amino acids is elevated in muscle. This may explain increased flux of alanine despite normal blood glucose control.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4065451     DOI: 10.1007/BF00265025

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  33 in total

Review 1.  The glucose-alanine cycle.

Authors:  P Felig
Journal:  Metabolism       Date:  1973-02       Impact factor: 8.694

2.  The metabolic response to glycemic control by the artificial pancreas in diabetic man.

Authors:  B Zinman; E F Stokes; A M Albisser; A K Hanna; H L Minuk; A N Stein; B S Leibel; E B Marliss
Journal:  Metabolism       Date:  1979-05       Impact factor: 8.694

3.  Normal alanine-glucose relationships and their changes in diabetic patients before and after insulin treatment.

Authors:  S E Hall; J T Braaten; J B McKendry; T Bolton; D Foster; M Berman
Journal:  Diabetes       Date:  1979-08       Impact factor: 9.461

4.  Gluconeogenesis from alanine in vivo by the ovine fetus and lamb.

Authors:  R L Prior; R K Christenson
Journal:  Am J Physiol       Date:  1977-12

5.  Glucose metabolism studied isotopically in diabetic dogs: effect of restoration of peripheral normoinsulinaemia by the artificial B cell.

Authors:  E J Freyse; U Fischer; G Albrecht
Journal:  Diabetologia       Date:  1983-11       Impact factor: 10.122

6.  In-vivo measurement of glucose and alanine metabolism with stable isotopic tracers.

Authors:  D M Bier; K J Arnold; W R Sherman; W H Holland; W F Holmes; D M Kipnis
Journal:  Diabetes       Date:  1977-11       Impact factor: 9.461

7.  Glucose and insulin effects on the novo amino acid synthesis in young men: studies with stable isotope labeled alanine, glycine, leucine, and lysine.

Authors:  J J Robert; D M Bier; X H Zhao; D E Matthews; V R Young
Journal:  Metabolism       Date:  1982-12       Impact factor: 8.694

8.  Alanine turnover in the postabsorptive state and during parenteral hyperalimentation before and after surgery.

Authors:  H P Sauerwein; R P Michels; V Cejka
Journal:  Metabolism       Date:  1981-07       Impact factor: 8.694

9.  Correction for the metabolic exchange of 14C for 12C atoms in the pathway of gluconeogenesis in vivo.

Authors:  G Hetenyi
Journal:  Fed Proc       Date:  1982-01

10.  Transfer of carbon atoms among circulating glucose, alanine, and lactate in pancreatectomized dogs.

Authors:  G Hetenyi; R A Layberry; D M Foster; M Berman
Journal:  Am J Physiol       Date:  1980-07
View more
  2 in total

1.  The effect of prehepatic insulin administration on alanine flux rates in diabetic dogs.

Authors:  E J Freyse; U Fischer; G Albrecht; S Marx; H Keilacker
Journal:  Diabetologia       Date:  1987-06       Impact factor: 10.122

2.  Differences in protein and energy metabolism following portal versus systemic administration of insulin in diabetic dogs.

Authors:  E-J Freyse; U Fischer; S Knospe; G C Ford; K S Nair
Journal:  Diabetologia       Date:  2006-01-31       Impact factor: 10.122

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.